Alchemist Chemsynth Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -57.90%
- Profit Growth 42.44%
- Ebitda 104.90%
- Net Worth 36.51%
- Total Assets -29.04%
About Alchemist Chemsynth Pharma
Alchemist Chemsynth Pharma Private Limited (ACPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 May 2018 (Six years and eight months 15 days old ). Its registered office is in Delhi, India.
The Corporate was formerly known as Alchemist Chemsynth Pharmaceutical Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hari Sharma and Kusum Sharma serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290DL2018PTC334185
-
Company No.
334185
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 May 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Alchemist Chemsynth Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hari Sharma
|
Director | 18-May-2018 | Current |
|
Kusum Sharma
|
Director | 22-Apr-2024 | Current |
Financial Performance of Alchemist Chemsynth Pharma.
Alchemist Chemsynth Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 57.9% decrease. The company also saw a substantial improvement in profitability, with a 42.44% increase in profit. The company's net worth Soared by an impressive increase of 36.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alchemist Chemsynth Pharma?
Unlock access to Alchemist Chemsynth Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Chemsynth Drugs & Pharmaceuticals Private LimitedHari Sharma and Kusum Sharma are mutual person
-
Vicint Biosciences Private LimitedHari Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alchemist Chemsynth Pharma?
Unlock and access historical data on people associated with Alchemist Chemsynth Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alchemist Chemsynth Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alchemist Chemsynth Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
